Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Breast Cancer Res Treat ; 145(3): 683-95, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24756186

RESUMO

Depression, anxiety and sleep disturbances are known problems in patients with breast cancer. The effect of melatonin as an antidepressant in humans with cancer has not been investigated. We investigated whether melatonin could lower the risk of depressive symptoms in women with breast cancer in a three-month period after surgery and assessed the effect of melatonin on subjective parameters: anxiety, sleep, general well-being, fatigue, pain and sleepiness. Randomized, double-blind, placebo-controlled trial undertaken from July 2011 to December 2012 at a department of breast surgery in Copenhagen, Denmark. Women, 30-75 years, undergoing surgery for breast cancer and without signs of depression on Major Depression Inventory (MDI) were included 1 week before surgery and received 6 mg oral melatonin or placebo for 3 months. The primary outcome was the incidence of depressive symptoms measured by MDI. The secondary outcomes were area under the curve (AUC) for the subjective parameters. 54 patients were randomized to melatonin (n = 28) or placebo (n = 26) and 11 withdrew from the study (10 placebo group and 1 melatonin group, P = 0.002). The risk of developing depressive symptoms was significantly lower with melatonin than with placebo (3 [11 %] of 27 vs. 9 [45 %] of 20; relative risk 0.25 [95 % CI 0.077-0.80]), giving a NNT of 3.0 [95 % CI 1.7-11.0]. No significant differences were found between AUC for the subjective parameters. No differences in side effects were found (P = 0.78). Melatonin significantly reduced the risk of depressive symptoms in women with breast cancer during a three-month period after surgery.


Assuntos
Ansiedade/tratamento farmacológico , Neoplasias da Mama/cirurgia , Depressores do Sistema Nervoso Central/uso terapêutico , Depressão/tratamento farmacológico , Melatonina/uso terapêutico , Adulto , Idoso , Antidepressivos/efeitos adversos , Antidepressivos/uso terapêutico , Depressores do Sistema Nervoso Central/efeitos adversos , Método Duplo-Cego , Fadiga/tratamento farmacológico , Feminino , Humanos , Mastectomia , Melatonina/efeitos adversos , Pessoa de Meia-Idade , Placebos , Transtornos do Sono-Vigília/tratamento farmacológico , Inquéritos e Questionários , Resultado do Tratamento
2.
Am J Surg ; 210(2): 389-95, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25678472

RESUMO

BACKGROUND: Chronic sleep deprivation combined with work during the night is known to affect performance and compromise residents' own safety. The aim of this study was to examine markers of circadian rhythm and the sleep-wake cycle in surgeons working night shifts. METHODS: Surgeons were monitored prospectively for 4 days: pre call, on call, post call day 1 (PC1), and post call day 2 (PC2). The urinary metabolite of melatonin and cortisol in saliva were measured to assess the circadian rhythm. Sleep and activity were measured by actigraphy. Subjective measures were assessed by the Karolinska Sleepiness Scale and Visual Analog Scale of fatigue, general well-being, and sleep quality. RESULTS: For both metabolite of melatonin and cortisol, a significant difference (P < .05) was found in the measurement period between on call and pre call values. There was increased sleep time during the day on call and on PC1. For all subjective measures, a marked deterioration was seen on PC1. CONCLUSION: Surgeons' circadian rhythm was affected by working night shifts.


Assuntos
Ritmo Circadiano/fisiologia , Internato e Residência , Privação do Sono , Sono/fisiologia , Especialidades Cirúrgicas , Tolerância ao Trabalho Programado , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
3.
J Surg Educ ; 71(4): 543-50, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24813717

RESUMO

OBJECTIVE: To monitor surgeons' performance and cognition during night shifts. DESIGN: Surgeons were monitored before call and on call (17-hour shift). Psychomotor performance was assessed by laparoscopic simulation and cognition by the d2 test of attention. The surgeons performed the laparoscopic simulation and the d2 test of attention at 8 a.m. before call and at 4 a.m. on call. Sleep was measured by wrist actigraphy and sleepiness by the Karolinska sleepiness scale. SETTING: Department of Surgery at Herlev Hospital, Denmark. PARTICIPANTS: Overall, 30 interns, residents, and attending surgeons were included and completed the study. One participant was subsequently excluded owing to myxedema. RESULTS: The surgeons slept significantly less on call than before call. There was increasing sleepiness on call; however, no significant differences were found in the precall laparoscopic simulation values compared with on-call values. The d2 test of attention showed significantly improved values on call compared with before call. CONCLUSION: Sleep deprivation during a 17-hour night shift did not impair surgeons' psychomotor or cognitive performance.


Assuntos
Competência Clínica , Cirurgia Geral , Laparoscopia , Desempenho Psicomotor , Transtornos do Sono do Ritmo Circadiano/epidemiologia , Actigrafia , Adulto , Atenção , Cognição/fisiologia , Feminino , Humanos , Internato e Residência , Masculino , Privação do Sono/fisiopatologia , Transtornos do Sono do Ritmo Circadiano/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA